Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-25-162670
Filing Date
2025-07-22
Accepted
2025-07-22 17:16:02
Documents
1
Group Members
RIDGEWAY ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d98536dsctota.htm SC TO-T/A 21164
  Complete submission text file 0001193125-25-162670.txt   22987
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-92605 | Film No.: 251141039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)